Influence of CYP2C9 polymorphisms on the pharmacokinetics and cholesterol-lowering activity of (-)-3S,5R-fluvastatin and (+)-3R,5S-fluvastatin in healthy volunteers (Q44532794)
Jump to navigation
Jump to search
scientific article published in August 2003
- Influence of CYP2C9 polymorphisms on the pharmacokinetics and cholesterol-lowering activity of (−)-3s,5r-fluvastatin and (+)-3r,5s-fluvastatin in healthy volunteers
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Influence of CYP2C9 polymorphisms on the pharmacokinetics and cholesterol-lowering activity of (-)-3S,5R-fluvastatin and (+)-3R,5S-fluvastatin in healthy volunteers |
scientific article published in August 2003 |
|
Statements
1 reference
Influence of CYP2C9 polymorphisms on the pharmacokinetics and cholesterol-lowering activity of (-)-3S,5R-fluvastatin and (+)-3R,5S-fluvastatin in healthy volunteers (English)
1 reference
Julia Kirchheiner
1 reference
Dirk Kudlicz
1 reference
Christian Meisel
1 reference
Steffen Bauer
1 reference
Ingolf Meineke
1 reference
Ivar Roots
1 reference
Jürgen Brockmöller
1 reference
1 August 2003
1 reference
1 reference
Identifiers
1 reference